Answers are grounded in this paper and cite their sources.
Blood biomarkers are widely used in clinical settings to support disease diagnosis and monitor therapeutic outcomes. Numerous genes associated with blood markers have been identified to date using gene prioritizing approach based on genome-wide association studies. As a complementary approach to traditional single-variant analyses, gene-based association analysis provides an alternative strategy for gene discovery by aggregating variants within genes. In this study, we applied this method to identify novel genes for blood marker levels that were not prioritized or included in a leading resource for such genes, namely the Open Targets platform. Using UK Biobank summary statistics, we performed gene-based association analyses for set of 30 blood markers and identified 132 novel gene–marker associations. We demonstrated that these genes participate in gene networks relevant to the corresponding markers and are enriched in specific metabolic pathways and processes. Furthermore, 51 of the 132 gene–marker associations were subsequently assigned high-priority scores in an updated Open Targets release. Collectively, our findings not only uncover new genes influencing blood marker levels but also demonstrate that gene-based association analysis can effectively complement traditional single-variant analyses by providing independent evidence to refine and inform gene prioritization efforts.
No takes yet. Share an insight, caveat, or question.
Zorkoltseva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: